These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 22429537)
1. Vitreomacular traction in a case of exudative age-related macular degeneration resistant to anti-VEGF therapy. Shah SU; Haller JA Acta Ophthalmol; 2012 Nov; 90(7):e569-70. PubMed ID: 22429537 [No Abstract] [Full Text] [Related]
2. Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab. Bakall B; Folk JC; Boldt HC; Sohn EH; Stone EM; Russell SR; Mahajan VB Am J Ophthalmol; 2013 Jul; 156(1):15-22.e1. PubMed ID: 23706500 [TBL] [Abstract][Full Text] [Related]
9. Topical bromfenac as an adjunctive treatment with intravitreal ranibizumab for exudative age-related macular degeneration. Gomi F; Sawa M; Tsujikawa M; Nishida K Retina; 2012 Oct; 32(9):1804-10. PubMed ID: 22718152 [TBL] [Abstract][Full Text] [Related]
10. The pearl necklace sign: a novel spectral domain optical coherence tomography finding in exudative macular disease. Gelman SK; Freund KB; Shah VP; Sarraf D Retina; 2014 Oct; 34(10):2088-95. PubMed ID: 25020214 [TBL] [Abstract][Full Text] [Related]
11. Role of posterior vitreous detachment on outcome of anti-vascular endothelial growth factor treatment in age-related macular degeneration. Üney GÖ; Ünlü N; Acar MA; Hazirolan D; Altiparmak UE; Yalniz-Akkaya Z; Örnek F Retina; 2014 Jan; 34(1):32-7. PubMed ID: 23751943 [TBL] [Abstract][Full Text] [Related]
12. Time to first treatment: The significance of early treatment of exudative age-related macular degeneration. Rauch R; Weingessel B; Maca SM; Vecsei-Marlovits PV Retina; 2012 Jul; 32(7):1260-4. PubMed ID: 22186738 [TBL] [Abstract][Full Text] [Related]
13. [Responses to ranibizumab in wet age-related macular degeneration patients with vitreomacular traction]. Filloy A; Arias L Arch Soc Esp Oftalmol; 2013 Oct; 88(10):380-6. PubMed ID: 24060301 [TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor in patients with exudative age-related macular degeneration treated with ranibizumab. Muether PS; Hermann MM; Viebahn U; Kirchhof B; Fauser S Ophthalmology; 2012 Oct; 119(10):2082-6. PubMed ID: 22920670 [TBL] [Abstract][Full Text] [Related]
15. Three-year follow-up of a pilot study of ranibizumab combined with proton beam irradiation as treatment for exudative age-related macular degeneration. Park SS; Daftari I; Phillips T; Morse LS Retina; 2012 May; 32(5):956-66. PubMed ID: 22183743 [TBL] [Abstract][Full Text] [Related]
16. Treatment of wet age-related macular degeneration by ranibizumab in "real life" in France: treatment behaviours and associated visual outcome. Souied EH; Cohen SY; de Pouvourville G; Dupeyron G; Latour E; Ponthieux A; Weber M Acta Ophthalmol; 2015 Mar; 93(2):e179-80. PubMed ID: 25377519 [No Abstract] [Full Text] [Related]
17. Circulating antiretinal antibodies predict the outcome of anti-VEGF therapy in patients with exudative age-related macular degeneration. Kubicka-Trząska A; Wilańska J; Romanowska-Dixon B; Sanak M Acta Ophthalmol; 2012 Feb; 90(1):e21-4. PubMed ID: 21883989 [TBL] [Abstract][Full Text] [Related]
18. Growth of type 1 neovascularization following cessation of anti-vascular endothelial growth factor therapy as a possible explanation for treatment resistance. Shah VP; Freund KB JAMA Ophthalmol; 2013 Jul; 131(7):967-9. PubMed ID: 23846209 [No Abstract] [Full Text] [Related]
19. Bevacizumab vs ranibizumab for age-related macular degeneration: early results of a prospective double-masked, randomized clinical trial. Donahue SP; Recchia F; Sternberg P Am J Ophthalmol; 2010 Aug; 150(2):287; author reply 287. PubMed ID: 20670740 [No Abstract] [Full Text] [Related]
20. Efficacy of vitrectomy and inner limiting membrane peeling in age-related macular degeneration resistant to anti-vascular endothelial growth factor therapy, with vitreomacular traction or epiretinal membrane. Kimura S; Morizane Y; Toshima S; Hosogi M; Kumase F; Hosokawa M; Shiode Y; Fujiwara A; Shiraga F Graefes Arch Clin Exp Ophthalmol; 2016 Sep; 254(9):1731-6. PubMed ID: 26951250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]